DaVita Inc. 2nd Quarter 2021 Results Denver, Colorado, August 3, 2021 - DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2021. For the quarter, diluted earnings per share from continuing operations was $2.64, an increase of 63.0% from the prior year diluted earnings per share from continuing operations and an increase of 35.4% from the prior year adjusted diluted earnings per share from continuing operations. 'We had a strong quarter despite the continued operational challenges presented by the pandemic. Our teammates and nephrologist partners have shown tremendous dedication to caring for our patients, and we have continued to make progress in our efforts to combat COVID-19 over the past several months,' said Javier Rodriguez, CEO of DaVita Inc. 'Additionally, we accelerated our investments in integrated kidney care capabilities designed to improve patient outcomes, coordinate care, and lower overall costs. We have grown the number of patients under value-based care arrangements to approximately 10% of our U.S. dialysis patient census, and we expect to see significant growth in our integrated kidney care business over the next year.'